Pfizer targets Omicron variant with new vaccine trial

Pfizer and BioNTech are working on a trial to test a modified COVID-19 vaccine aimed at targeting the Omicron variant. Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBS News to discuss the latest on the pandemic.